Market Leader in Parenteral Nutrition, B. Braun Showcases Portfolio at ASHP
BETHLEHEM, PA – May 31, 2018 ─ B. Braun Medical Inc. will showcase its Parenteral Nutrition 360 (PN360) program – which is designed to improve neonatal, pediatric and adult patient outcomes – at this year’s American Society of Health-System Pharmacists (ASHP) Summer Meeting, June 3-5, at the Colorado Convention Center in Denver, Colorado.
Parenteral nutrition can be a life-saving therapy for clinical malnutrition in situations where enteral and oral feedings are not viable alternatives or are not enough. Often overlooked and under-diagnosed, clinical malnutrition not only wastes away the physical health of those affected, but also increases recovery time, infection rates, and healthcare costs. It is estimated that 20 to 50% of hospitalized adult patients are malnourished. 1,2
PN needs can vary depending upon the patient’s age, body composition, clinical status, and level of activity. Customized parenteral nutrition options provide an opportunity to create personalized nutrition that is as unique as the patient receiving it.
“B. Braun's PN360 program is individual in-house compounding of parenteral nutrition solutions and outsourced compounded products and services. It’s a team collaboration with pharmacists, physicians, nurses, and dietitians to tailor nutritional therapy for their most critical patients in an effort to help reduce medical errors, infections, and re-admissions,” said Tom Sutton, Vice President, Medical Device and Pharmaceutical Systems at B. Braun.
B. Braun’s wide selection of amino acids formulations and related additives are in containers not made with DEHP, PVC or natural rubber latex to help clinicians provide safe, appropriate nutritional support. B. Braun was the first medical device manufacturer to remove harmful DEHP and PVC from many of its products. To learn more about B. Braun’s commitment to protecting people and the environment while improving patient outcomes and reducing healthcare costs, visit www.bbrauncares.com.
Another integral part of PN360 is Central Admixture Pharmacy Services, Inc. (CAPS®), the nation’s largest network of outsourcing admixture pharmacies and a leader in customized parenteral nutrition. Pharmacy Systems Specialists will be at the booth to discuss CAPS’ customized parenteral nutrition compounding offering, including local, same-day delivery with easy online ordering.
B. Braun Representatives at booth #625 will showcase:
- APEX® Compounding System – for facilities that need in-house compounding capability, this innovative macro and micro compounder incorporates a large user interface, 26-lead preassembled sets, and dual-drive filling technology with automated delivery as low as 0.2 mL.
- OnGuard® CSTD – a closed system transfer device (CSTD) designed to protect healthcare workers from accidental exposure to hazardous drugs.
- PharmView Application through DoseTrac® – an infusion management software and its 2nd generation, large-volume Infusomat® Space Infusion Pump, including its AutoCOMPLETE™ Integrated EMR functions (AutoProgramming, AutoDocumentation, AutoNotification, and AutoLocation).
B. Braun also will introduce its Heparin Sodium Injection 5,000 Units/0.5 mL – a pre-filled, single dose glass syringe, which is pending FDA-Approval.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include ostomy and wound care, dialysis, nutrition, pharmacy admixture and compounding. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
1 Smith, Susan, et al. MALNUTRITION IN HOSPITALIZED ADULT PATIENTS The Role of the Clinical Nurse Specialist. National Association of Clinical Nurse Specialists, 2017, pp. 1–22, MALNUTRITION IN HOSPITALIZED ADULT PATIENTS The Role of the Clinical Nurse Specialist.
2 Kirkland, L. L., Kashiwagi, D. T., Brantley, S., Scheurer, D. and Varkey, P. (2013), Nutrition in the hospitalized patient. J. Hosp. Med., 8: 52–58. doi:10.1002/jhm.1969